Market closed
Twist Bioscience/$TWST
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Twist Bioscience
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of its revenue from the United States.
Ticker
$TWST
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
919
Website
Twist Bioscience Metrics
BasicAdvanced
$2.7B
Market cap
-
P/E ratio
-$3.82
EPS
1.80
Beta
-
Dividend rate
Price and volume
Market cap
$2.7B
Beta
1.8
52-week high
$60.90
52-week low
$15.99
Average daily volume
615K
Financial strength
Current ratio
4.906
Quick ratio
4.358
Long term debt to equity
14.787
Total debt to equity
17.751
Interest coverage (TTM)
-189,942.00%
Management effectiveness
Return on assets (TTM)
-16.39%
Return on equity (TTM)
-38.36%
Valuation
Price to revenue (TTM)
8.842
Price to book
5.39
Price to tangible book (TTM)
6.78
Price to free cash flow (TTM)
-34.83
Growth
Revenue change (TTM)
25.37%
Earnings per share change (TTM)
3.38%
3-year revenue growth (CAGR)
32.53%
3-year earnings per share growth (CAGR)
9.86%
What the Analysts think about Twist Bioscience
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Twist Bioscience stock.
Twist Bioscience Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Twist Bioscience Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Twist Bioscience News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Twist Bioscience stock?
Twist Bioscience (TWST) has a market cap of $2.7B as of November 14, 2024.
What is the P/E ratio for Twist Bioscience stock?
The price to earnings (P/E) ratio for Twist Bioscience (TWST) stock is 0 as of November 14, 2024.
Does Twist Bioscience stock pay dividends?
No, Twist Bioscience (TWST) stock does not pay dividends to its shareholders as of November 14, 2024.
When is the next Twist Bioscience dividend payment date?
Twist Bioscience (TWST) stock does not pay dividends to its shareholders.
What is the beta indicator for Twist Bioscience?
Twist Bioscience (TWST) has a beta rating of 1.8. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.